Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MGD-014 by MacroGenics for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
MGD-014 is under clinical development by MacroGenics and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS). According...